The DOI matches its Crossref record; 27 of the 29 references it cites were found in a registry or an index, and 1 are not checked yet.
Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Outpatients—A Systematic Review and Meta-Analysis
Open accessAbstract
A common adverse effect of antibiotic use is diarrhea. Probiotics are living microorganisms, which, upon oral ingestion, may prevent antibiotic-associated diarrhea (AAD) by the normalization of an unbalanced gastrointestinal flora. The objective of this systematic review was to assess the benefits and harms of probiotics used for the prevention of AAD in an outpatient setting. A search of the PubMed database was conducted and yielded a total of 17 RCTs with 3631 participants to be included in the review. A meta-analysis was conducted for the primary outcome: the incidence of AAD. The pooled results found that AAD was present in 8.0% of the probiotic group compared to 17.7% in the control group (RR 0.49, 95% CI 0.36 to 0.66; I2 = 58%), and the species-specific results were similar regarding the probiotic strains L. rhamnosus GG and S. boulardii. However, the overall quality of the included studies was moderate. A meta-analysis of the ten trials reporting adverse events demonstrated no statistically significant differences in the incidence of adverse events between the intervention and control group (RD 0.00, 95% CI −0.02 to 0.02, 2.363 participants). The results suggests that probiotic use may be beneficial in the prevention of AAD among outpatients. Furthermore, the use of probiotics appears safe.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to modulating the immune system, the positive health effects of taking probiotics include: the improvement of lactose tolerance and digestion [199,205], the prevention and treatment of gastrointestinal infections [206], the prevention of colorectal cancer [203,207], reduction in blood cholesterol levels [208,209,210], and the improvement of mental health via the gut-brain axis [211].”
From Lactic Acid Bacteria in Raw-Milk Cheeses: From Starter Cultures to Probiotic Functions (2022) · cites this paper as [206]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing Risk of Bias in Included Studies
Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch8 · Cited by 3,396
Outpatient antibiotic use in Europe and association with resistance: a cross-national database study
Goossens, H., Ferech, M., Vander Stichele, R., & Elseviers, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17907-0 · Cited by 3,359 · cited 1×
“The primary care sector is responsible for the bulk of antibiotic consumption in humans [3].”
BackgroundThe Role of Probiotic Cultures in the Control of Gastrointestinal Health
Rolfe, R. D. (2000) · Journal of Nutrition · doi:10.1093/jn/130.2.396s · Cited by 925 · cited 1×
“intestinal health, including the stimulation of immunity, competition for nutrients, the inhibition of the epithelial and mucosal adherence of pathogens, the inhibition of epithelial invasion, and the production of antimicrobial substances [5].”
BackgroundNewberry, S. J. (2012) · JAMA · doi:10.1001/jama.2012.3507 · Cited by 870 · cited 1×
“as a review, including hospitalized patients [26], on the prevention and treatment of AAD regardless of age (RR 0.”
BackgroundProbiotics for the prevention of pediatric antibiotic-associated diarrhea
Goldenberg, J. Z., Lytvyn, L., Steurich, J., Parkin, P. C., Mahant, S., & Johnston, B. C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004827.pub4 · Cited by 635
Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children
Vanderhoof, J. A., Whitney, D. B., Antonson, D. L., Hanner, T. L., Lupo, J. V., & Young, R. J. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70053-3 · Cited by 536 · cited 1×
“, 1999 [8] Lactobacillus rhamnosus GG Children < 12 kg: 1 × 1010 CFU, once daily Children > 12 kg: 2 × 1010, once daily 10 days”
Wiström, J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.1.43 · Cited by 455 · cited 1×
“In particular, aminopenicillins, cephalosporins, and clindamycin that act on anaerobes are associated with a high risk of AAD [2].”
BackgroundArvola, T., Laiho, K., Torkkeli, S., Mykkänen, H. M., Salminen, S., Maunula, L., & Isolauri, E. (1999) · PEDIATRICS · doi:10.1542/peds.104.5.e64 · Cited by 426 · cited 1×
“, 1999 [9] Lactobacillus rhamnosus GG 2 × 1010 CFU, twice daily Seven to 10 days”
Epidemiology, Risk Factors and Treatments for Antibiotic-Associated Diarrhea
McFarland, L. V. (1998) · Digestive Diseases · doi:10.1159/000016879 · Cited by 310 · cited 1×
“Antibiotic-associated diarrhea (AAD) occurs in 5% to 39% of patients, from the beginning and up to two months after the end of treatment [1].”
BackgroundSafety of probiotics used to reduce risk and prevent or treat disease.
(2011) · PubMed Central · Cited by 242
A review of dose-responses of probiotics in human studies
Ouwehand, A. C. (2016) · Beneficial Microbes · doi:10.3920/bm2016.0140 · Cited by 233 · cited 1×
“A review investigating different treatment regimens of probiotics in human studies concluded that a dose-response relationship exists within the commonly studied range of 108 to 1011 CFU, meaning that, within this range, a higher dose will lead to a better response [25].”
BackgroundAntibacterial prescribing in primary care
Petersen, I., & Hayward, A. C. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm156 · Cited by 150
Tankanow, R. M., Ross, M. B., Ertel, I. J., Dickinson, D. G., McCormick, L. S., & GARFINKEL, J. (1990) · DICP · doi:10.1177/106002809002400408 · Cited by 140 · cited 1×
“, 1990 [7] Lactobacillus acidophilus Lactobacillus bulgaricus 5.”
BackgroundCindoruk, M., Erkan, G., Karakan, T., Dursun, A., & Unal, S. (2007) · Helicobacter · doi:10.1111/j.1523-5378.2007.00516.x · Cited by 135 · cited 1×
“, 2007 [13] Saccharomyces boulardii 500 mg, twice daily 14 days”
BackgroundFox, M. J., Ahuja, K., Robertson, I. K., Ball, M., & Eri, R. D. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-006474 · Cited by 117 · cited 1×
“, 2014 [22] Lactobacillus rhamnosus, G.”
The Effects of Probiotics on PPI‐Triple Therapy for Helicobacter pylori Eradication
Kim, M., Kim, N., Lee, S. H., Park, Y. S., Hwang, J., Kim, J., Jeong, S., Lee, D. H., Kim, J. S., Jung, H. C., et al. (2008) · Helicobacter · doi:10.1111/j.1523-5378.2008.00601.x · Cited by 115 · cited 1×
“, 2008 [16] Lactobacillus acidophilus Lactobacillus casei Bifidobacterium longum Streptococcus thermophilus One bottle (150 mL) per day: >1 × 105 CFU/mL (L.”
BackgroundDuman, D., Bor, S., ??z??temiz, ?., ahin, T. L., uz, D. O., tan, F. I., Vural, T., Sandkci, M., ksal, F. I., ek, L. I., et al. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200512000-00015 · Cited by 104 · cited 1×
“, 2005 [11] Saccharomyces boulardii 500 mg, twice daily 14 days”
BackgroundOjetti, V., Bruno, G., Ainora, M. E., Gigante, G. E., Rizzo, G., Roccarina, D., & Gasbarrini, A. (2012) · Gastroenterology Research and Practice · doi:10.1155/2012/740381 · Cited by 90
de Vrese, M., Kristen, H., Rautenberg, P., Laue, C., & Schrezenmeir, J. (2011) · Journal of Dairy Research · doi:10.1017/s002202991100063x · Cited by 84 · cited 2×
“…longum Bifidobacterium breve Lactobacillus acidophilus Saccharomyces florentinus One bottle (150 mL) per day, amount of CFU not mentioned 10 days De Vrese et al., 2011 [18] Lactobacillus acidophilus LA-5Bifidobacterium lactis BB-12 >1 × 10 6 CFU/g, 125 g, twice daily Five weeks Ojetti et al., 2013…”
BackgroundImase, K., Takahashi, M., Tanaka, A., Tokunaga, K., Sugano, H., Tanaka, M., Ishida, H., Kamiya, S., & Takahashi, S. (2008) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00026.x · Cited by 81 · cited 1×
“, 2008 [15] Clostridium butyricum 1 × 107 CFU per tablet Group B: two tablets, three times daily Group C: 4 tablets, three times daily Seven days”
BackgroundThe Probiotic Effect of Saccharomyces boulardii in a Pediatric Age Group
Erdeve, Ö. (2004) · Journal of Tropical Pediatrics · doi:10.1093/tropej/50.4.234 · Cited by 75 · cited 1×
“, 2004 [10] Saccharomyces boulardii Not mentioned Not mentioned”
BackgroundConway, S., Hart, A. R., Clark, A., & Harvey, I. M. (2007) · British Journal of General Practice · doi:10.3399/096016407782604811 · Cited by 71 · cited 1×
“, 2007 [14] Lactobacillus acidophilus 109 CFU, once daily 12 days Streptococcus thermophilus Bifidobacterium animalis lactis”
BackgroundMerenstein, D. J., Foster, J., & D’Amico, F. (2009) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2009.119 · Cited by 61 · cited 3×
“RCT Probiotic(s) Used (Genus and Strain) Dosage Duration of Treatment Merenstein et al., 2009 [17] Lactococcus lactis Lactococcus plantarum Lactococcus rhamnosus Lactococcus casei Lactococcus lactis subspecies diacetylactis Leuconostoc cremoris Bifidobacterium longum Bifidobacterium breve Lactobacillus acidophilus Sac…”
BackgroundMethodInfluentialEffect of Probiotics on Helicobacter Pylori Eradication
Park, S. K., Park, D. I., Choi, J. S., Kang, M.-S., Park, J. H., Kim, H. J., Cho, Y. K., Sohn, C. I., Jeon, W. K., & Kim, B. I. (2019) · Case Medical Research · doi:10.31525/ct1-nct04034641 · Cited by 55 · cited 1×
“, 2007 [12] Bacillus subtilis Streptococcus faecium two capsules three times a day: 2.”
BackgroundOlek, A., Woynarowski, M., Ahrén, I. L., Kierkuś, J., Socha, P., Larsson, N., & Önning, G. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.03.047 · Cited by 46 · cited 3×
“, 2017 [23] Lactobacillus plantarum DSM9843 (LP299V) 1 × 1010 CFU/capsule Five to 10 days during antibiotic treatment and one week after (±two days)”
BackgroundInfluentialChatterjee, S., Kar, P., Das, T., Ray, S., Gangulyt, S., Rajendiran, C., & Mitra, M. (2013) · PubMed · Cited by 45
Zojaji, H., Ghobakhlou, M., Rajabalinia, H., Ataei, E., Sherafat, S. J., Moghimi-Dehkordi, B., & Bahreiny, R. (2013) · Gastroenterology and hepatology from bed to bench. · Cited by 30
Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Johnston, B., Wiebe, N., Crumley, E. T., Supina, A. L., & Vohra, S. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004827 · Cited by 11
Research works printed but not linked: 2
- WHO (2009). Appendix 1, Definitions of health-care settings and other related terms. Guidelines on Hand Hygiene in Health Care: First Global Patient Safety Challenge Clean Care Is Safer Care, World Health Organization. Available online: https://www.ncbi.nlm.nih.gov/books/NBK144006/.
- (2014). Review Manager (RevMan) [Computer program]. Version 5.3, The Cochrane Collaboration.
Cited by
Sorted by citations
Role of Probiotics in Human Gut Microbiome-Associated Diseases
Kim, S.-K., Guevarra, R. B., Kim, Y.-T., Kwon, J., Kim, H., Cho, J. H., Kim, H. B., & Lee, J.-H. (2019) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1906.06064 · Cited by 519
Thirty Years of Lactobacillus rhamnosus GG
Capurso, L. (2019) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001170 · Cited by 400
Lactic Acid Bacteria in Raw-Milk Cheeses: From Starter Cultures to Probiotic Functions
Coelho, M. C., Malcata, F. X., & Silva, C. C. G. (2022) · Foods · doi:10.3390/foods11152276 · Cited by 276
“…probiotics include: the improvement of lactose tolerance and digestion [199,205], the prevention and treatment of gastrointestinal infections [206], the prevention of colorectal cancer [203,207], reduction in blood cholesterol levels [208 – 210], and the improvement of mental health via the…”
Shah, A. B., Baiseitova, A., Zahoor, M., Ahmad, I., Ikram, M., Bakhsh, A., Shah, M. A., Ali, I., Idress, M., Ullah, R., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2431643 · Cited by 220
Critical Appraisal of Oral Pre- and Probiotics for Caries Prevention and Care
Zaura, E., & Twetman, S. (2019) · Caries Research · doi:10.1159/000499037 · Cited by 137
“…probiotic bacteria exert a mix of local and systemic events [Reid, 2016] with good and reliable evidence from systematic reviews for relieving diarrhea, atopic diseases and respiratory infections [Zuccotti et al., 2015; Blaabjerg et al., 2017; Goldenberg et al., 2017; Laursen and Hojsak, 2018].”
Background
Metadata
- Authors
- Blaabjerg, S., Artzi, D., & Aabenhus, R.
- Affiliations
- University of Copenhagen (DK)
- Corresponding author
- Blaabjerg, Sara
- Artzi, Daniel
- Aabenhus, Rune
- ORCID
- Aabenhus, Rune
- Venue
- Antibiotics
- Publisher
- MDPI AG
- Published
- 2017-10-12
- Volume
- 6
- Issue
- 4
- Pages
- 21
- ISSN
- 2079-6382 (ISSN-L)
- PMC
- PMC5745464
- OpenAlex
- W2762238784
- Cited by
- 208
- References
- 29
- Citations by year
- 2026: 17 · 2025: 18 · 2024: 27 · 2023: 24 · 2022: 31 · 2021: 27 · 2020: 32 · 2019: 25 · 2018: 7
- FWCI
- 1.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Antibiotics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- probiotics, antibiotic-associated diarrhea, diarrhea prevention, outpatients, Lactobacillus rhamnosus GG, Saccharomyces boulardii, adverse events, gut microbiota, antibiotic adverse effects
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
